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Pío del Río-Hortega: A Visionary in
the Pathology of Central Nervous
System Tumors
Santiago Ramon y Cajal Agüeras*
Pathology Department, Vall d’Hebron University Hospital, Universidad Autónoma of Barcelona, Barcelona, Spain
The last 140 years have seen considerable advances in knowledge of central nervous
system tumors. However, the main tumor types had already been described during the
early years of the twentieth century. The studies of Dr. Pío del Río Hortega have been
ones of the most exhaustive histology and cytology-based studies of nervous system
tumors. Río Hortega’s work was performed using silver staining methods, which require
a high level of practical skill and were therefore difficult to standardize. His technical
aptitude and interest in nervous system tumors played a key role in the establishment
of his classification, which was based on cell lineage and embryonic development. Río
Hortega’s approach was controversial when he proposed it. Current classifications are
not only based on cell type and embryonic lineage, as well as on clinical characteristics,
anatomical site, and age.
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INTRODUCTION
I am satisfied to be able to summarize the contribution of Pío del Río Hortega to the field of
neuropathology, in particular, tumors of the central nervous system. As a pathologist, I am keenly
aware of the classifications of central nervous system tumors and can now provide a context for
many of the contributions of Dr. Pío del Río Hortega.
As stated in other sections of this monograph, Río de Hortega was an illustrious character, both
at the human level and at the scientific level. A self-taught man with an extraordinary knowledge
of laboratory techniques, he was a leading scientific figure in the cities where he worked. The
combination of expertise, dedication, and an undeniable persistence and capacity for work, together
with considerable talent, led him to make key discoveries in the history of neuroscience, including
microglia and oligodendroglia (as described in other chapters of this Special research Topic; see
Pérez-Cerdá et al., 2015; Tremblay et al., 2015).
His techniques, especially the silver carbonate staining method, enabled him to work on tumors
of the central nervous system and develop his highly practical classification (Polak, 1947; Llombart
Rodríguez, 1965; Obrador, 1965).
HISTORICAL CONTEXT
The first descriptions of brain tumors date from the period of Virchow, who described gliomas
arising from neuroglial cells. Virchow made a distinction between myxoglioma, gliosarcoma,
glioma durum, and glioma hemorrhagicum, which are composed of glial cells that sometimes
contained fibers. Virchow’s pioneering comparison of neoplastic cells with normal brain tissue
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laid down the scientific foundations for all subsequent
classifications of tumors of the central nervous system. The
main studies at the end of the nineteenth century and beginning
of the twentieth century were performed by Simon (1874), who
described spider cell glioma, and Tooth and Conheim, who
reported that tumors arose from embryonic remnants.
Between 1900 and 1950, the various classifications of central
nervous system tumors led to decades of confusion over
terminology. The more notable studies of the period were by
Ribbert (1910, 1918) who speculated about the histogenesis and
etiology of glioma, particularly in his paper on spongioblastoma
and glioma (“Über das Spongioblastoma und das Gliom” [On
spongioblastoma and glioma]). Some authors feel that this
study had a negative effect on the classifications of glioma
that were produced during the following 20 years. In his
study, which was based on theoretical deductions, Ribbert
concluded that differentiated glial areas can never return to a
lower grade of differentiation and that gliomas, glioblastomas,
and spongioblastomas would therefore necessarily have to be
explained by the presence of embryonic remnants whose growth
had stopped at various stages of differentiation. According to
this hypothesis, Ribbert believed that tumors stemmed from
embryonic stages and not from changes occurring in the most
differentiated cells. Nevertheless, Ribbert paved the way for
the cytological study of tumors and for more specific studies
based on impregnation methods, of which Río Hortega was a
major proponent. The histogenetic and embryological approach
adopted by Ribbert was modified by the cellular approach
espousedmainly by RíoHortega. The contributions of the French
school (Lhermitte and Dumas, 1916; Cornil, 1924; Roussy and
Oberling, 1932) around the 1920 made it possible to distinguish
between fibrillary astrocytoma, four subgroups of non-fibrillary
glioma (round, spindle-shaped, polymorphic, and ameboid
cells), glioblastoma, and spongioblastoma. The classification
included ependymomas with choroid plexus tumors, which were
separate from the other gliomas. The histogenetic approach
was maintained in the studies by Globus and Strauss (1925)
and in those of Bailey and Cushing (1926), where a distinction
is made between various histogenetic cell types in glioma.
The authors recognize the considerable internal heterogeneity
of these tumors, to the extent that their classification placed
considerable emphasis on the predominant cell type. The
same authors performed an exhaustive study of brain tumors
based on morphologic characteristics and on correlations with
the patient’s prognosis after surgery (Bailey, 1924; Bailey and
Bucy, 1929). Their classification developed from the concept
that tumor cells could arise from a medullary epithelium
parent cell, which could differentiate into other glial, neural,
or choroid cells. These cells could then differentiate even
further. In theory, tumors could develop at each of these
phases of differentiation. This period saw the first description
of oligodendromas and cerebellar medulloblastomas. Although
these tumors had been described as sarcomas or neuroblastomas
by other authors, Bailey and Cushing (1925) have the merit
of separating them from neuroblastoma based on their gross
appearance, origin, form of growth, and spread along the spinal
cord.
The 1926 classification of Bailey and Cushing is similar to
the present one. It distinguished between tumors of the central
nervous parenchyma, as follows:
(1) Astrocytoma (grades I–IV), pilocytic astrocytoma,
glioblastomamultiforme, oligodendroglioma, ependymoma,
choroid plexus papilloma, pinealoma, colloid cyst, and
medulloblastoma.
(2) Meningeal tumors: meningioma, malignant meningioma,
meningeal sarcoma, and meningiomatosis.
(3) Tumors of the cranial pairs: neurinoma.
(4) Tumors of the pituitary gland: adenoma, invasive adenoma,
carcinoma, and craniopharyngioma.
(5) Vascular tumors: hemangioblastoma.
(6) Embryonal tumors: dermoid cysts and teratomas.
This classification had an enormous impact on neuroscience
and neurosurgery, although it was criticized by several authors,
mainly Scherer, who stressed the lack of correlation between
clinical and pathological aspects in several tumors and the fact
that a very high number of tumors (up to 30%) could not
be classified following the authors’ criteria. In parallel, authors
such as Cushing focused on clinical classifications that described
tumors with a favorable prognosis, for example cerebellar
astrocytoma, which they stressed was different from cerebral
astrocytoma, despite the histogenetic similarity between the two.
Using data from studies of the child brain, the authors described
non-recurring cystic tumors that were well-defined in terms of
growth stage and whose classification was highly relevant at the
time. This distinction was not based merely on histogenetic and
cytologic principles, but on clinical, histopathologic, and clinical
data. Important as well the contributions of Penfield (1931).
The publications and lectures of Río Hortega during the 1930s
played a major role in promoting histogenetic classification,
largely thanks to very accurate silver staining techniques. Most
authors from this period and thereafter felt that his classification
contained the most exhaustive collection of images until then.
Río Hortega’s classification was not based on clinical findings
or anatomical site, but on morphological and histogenetic
data.
TUMORS OF THE CENTRAL NERVOUS
SYSTEM: THE CONTRIBUTION OF RÍO
HORTEGA
During the initial stage of his training, Río Hortega analyzed
brain tumors in four studies. One of these was his doctoral
thesis (“Causas y Anatomía Patológica de los Tumores de
Encéfalo” [Causes and Histopathology of Brain Tumors]), which
he defended under the direction of his tutor, Leopoldo López
García, between the years 1911 and 1912.
Río Hortega wrote papers on the histopathology of
carcinomas and of the nervous system in patients with brain
tumors (1911a), the pathophysiology of brain tumors (1911b),
and abnormalities of nerve tissue and general symptoms of brain
tumors (Río-Hortega, 1911a,b, 1912, 1914a,b,c; Río-Hortega and
y Costero, 1928; Río-Hortega and y Álvarez Cascos, 1930).
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During the following phase of his training, Río Hortega
performed a study of subcutaneous giant cell glioma, the
results of which were published in 1926 (Río-Hortega, 1926).
The third phase (1928–1936) saw the appearance of his most
important contributions to the field of neuro-oncology. In 1930,
he published a series of monographs analyzing the cytologic and
histogenetic characteristics of specific tumor groups, beginning
with a detailed consideration of meningeal exotheliomas, which
he discussed and included in the differential diagnosis of
what was then known as Cushing meningioma. He described
variations of meningioma, such as xanthomatous tumors and
fascicular tumors, which have been reported sporadically by
other authors. The examination of these histopathologic forms
led him to propose three major patterns: (a) a predominantly
syncytial pattern; (b) a pattern based on fibrillary differentiation
of cytoplasm that tended to arrange itself in plaques and
bundles; and (c) a pattern involving more epithelioid and
lobulated morphological differentiation. Similarly, he described
the formation of acervuli and psammoma bodies in meningioma,
the pineal gland, and the colloid plexus (Río-Hortega, 1930c).
The year 1932 saw the publication of the major study
“La estructura y sistematización de los gliomas y paragliomas”
[Structure and systematization of gliomas and paragliomas],
which, with more than 260 pages and 200 images, was the fruit
of the techniques that Río Hortega had been developing using
mainly silver carbonate staining (Río-Hortega, 1932, 1933a,b).
He performed the study using his in-depth knowledge of
the histology of the glia and brain and had to seek the help of
neurosurgeons and other pathologists to compile a sufficiently
large series of brain tumor samples for study and classification.
The French neurosurgeon Clovis Vincent was of inestimable help
during this period.
The results, which were based on neuroembryological data,
pointed to four potential evolutionary pathways of the primitive
medullary epithelium (neuroblasts, glioblasts, pineoblasts, and
choroideoblasts). Given the considerably heterogeneous nature
of brain tumors, Río Hortega thought that it was important to
classify them into histologic types with common embryological
findings. Therefore, he tried to define two large groups of tumors,
with emphasis on histological and embryological lineage. The
first group comprised gliomas and the second paragliomas,
which included all those tumors formed by immature or mature
elements of the nervous system and tumors arising from
choroidal folds and the pineal gland.
His systematic typing of the gliomas according to the degree of
maturity of the cell components or the degree of differentiation
enabled him to define the following entities (Río-Hortega and
y Jiménez de Asúa, 1921; Río-Hortega, 1930a,b, 1932, 1933a,b;
Pineda et al., 1962; Diaz, 1985) (Figure 1):
(1) Embryonal glioblastoma or spongioblastoma.
(2) Heteromorphic glioblastoma.
(3) Isomorphic glioblastoma (Figures 2, 3).
(4) Astroblastoma.
(5) Astrocytoma (Figure 4).
(6) Oligodendroglioma, with a distinction between
oligodendrocytomas and oligodendroblastomas (Figure 5).
(7) Glioepitheliomas, which included ependymal tumors
(ependymocytoma and ependymoblastoma).
The classification of paragliomas included neuroma from
neuroblasts (neuroblastoma), neurocytoma, pineal tumors
(pinealcytoma, pineoblastoma), and choroid plexus tumors,
which he termed chorioepitheliomas (Figure 6).
At the International Cancer Congress on the Scientific and
Social Fight Against Cancer held in Madrid in 1933, he provided
a more extensive summary of his classification in a lecture based
on 287 pages of text (315 pages including the bibliography) and
248 images.
The classification, which to a certain extent complemented
those proposed by Roussy and Overling and especially that
proposed by Bailey and Cushing, differed in major areas, some
of which are worthy of mention. Río Hortega’s classification
was based on the cytologic and embryologic characteristics of
tumor cells, irrespective of their location, and therefore included
tumors such as cerebellar medulloblastoma alongside tumors
with a blastic lineage from within the brain. This distinction
between medulloblastomas and other neuroblastic or primitive
tumors was controversial at the time and continues to be so
today.
In his lecture, Río Hortega stressed the need for international
harmonization of the nomenclature applied to tumors of the
nervous system, as also proposed by Roussy and Overling. The
groups he suggested in the lecture were as follows:
(1) Tumors arising from choroidal folds, the pineal valve, and
homologous evaginations of the diencephalon that develop
in the embryo.
(2) Tumors arising in the parenchyma of the brain and spinal
cord and visual system, which is a prolongation of the brain.
(3) Tumors arising in the sympathetic nervous system, but not
all those that develop from sympathogonia.
(4) Tumors arising in the nerve roots and in the peripheral
nerves from interstitial cells or parenchymatous cells,
depending on the interpretation of neoplastic elements
(Figure 7).
(5) Tumors arising in the meninges owing to proliferation of
cells or to new vascular formations (Figure 8).
(6) Tumors arising from hyperplasia in the parenchyma of the
pituitary gland and from dislocated epidermal germ cells and
invaginations of the Rathke pouch.
The fourth stage of Río Hortega’s life (1936–1945), which was
spent in exile, saw the publication of several papers on the
nervous system (see below) (Río-Hortega, 1940a,b,c, 1941a,b,
1942, 1943).
In 1940, after his stay in Oxford, he performed a study on
tumors of the optic nerve. During the same year, once he had
settled in Argentina, he published a study on neuroblastomas, in
which he concluded that there were no nervous system tumors
with bipotential cells that were able to progress to neuroblasts or
glioblasts and thatmost of the so-calledmedulloblastomas should
be termed neuroblastomas, which is the term that corresponds to
their lineage. His approach was considered scientific in terms of
its embryological interpretation.
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FIGURE 1 | Morphological evolution of the cells that are derived from the neural epithelium in the central nervous system (taken from Río-Hortega,
1933a).
This interpretation remains controversial today. The
embryological approach did not take histopathological
characteristics into account. In addition, the neuroblastoma
group included tumors that developed from other precursors,
namely, medulloblasts, which develop in the molecular layer of
the cerebellum.
His paper entitled “Del glioepitelioma al glioblastoma
isomorfo” [From glioepithelioma to isomorphic glioblastoma],
which was published in 1941, discussed and criticized the use of
the term ependymoma—suggested by Bailey and Cushing—for
tumors associated with the ependymal wall.
In 1943, Río Hortega (Río-Hortega et al., 1943) performed
a cytological study of neurofibromas (also known as
lemmocytomas), in which he described the histologic
characteristics of the tumors and the elements that characterize
them. He made an in-depth examination of the constitution of
these tumors, discussed the identification of the main elements of
Schwann cells and the embryonic origin thereof, and examined
the specific differentiation of multiple neurofibromas and
neurinomas (solitary schwannomas). His findings remain in
force today.
He added new pathological information after previous papers
(Cushing, 1917; Kernohan et al., 1931; Kernohan and Ody, 1932;
Scherer, 1933).
In 1944, Río Hortega reported the results of an extensive
study on oligodendrogliomas, which he classed as a gliomatous
ectodermal variety characterized by small cells with a spherical
nucleus (Río-Hortega, 1944a,b). His description of the nucleus
as “very round” continues to be of use today in the
diagnosis of oligodendrogliomas. Similarly, he observed that
oligodendrocytes tend to be arranged in dense or diffuse patterns
and never in perivascular patterns. Río Hortega established three
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FIGURE 2 | Isomorphic glioblastoma, as termed by Rio-Hortega (taken
from Río-Hortega, 1933a).
FIGURE 3 | Another example of isomorphic glioblastoma with
wave-like arrangement of glioblasts (taken from Río-Hortega, 1933a).
cytological types of oligodendroglioma: (a) those whose cells have
a spherical nucleus surrounded by a characteristic light halo and
wrapped in a small layer of protoplasm that projects a varying
number of fine and long appendages; (b) a more infrequent
type of oligodendroglioma, which is formed by large neoplastic
oligodendrocytes; and (c) a type that includes tumors with a non-
uniform structure. As Río Hortega pointed out, the neoplastic
oligodendrocyte evolves morphologically to the extent that it
takes on the characteristics of an astrocytoma.
The year 1944 is also notable for Río Hortega’s cytological
study of tumors of the optic chiasm and nerve. The tumors
described at this level that can be classed as gliomas, which
were similar to brain tumors, with a moderately expansive
or infiltrative character. The several cell types that can
be identified for tumors of the optic nerve and chiasm
include the following: (1) cells with small, round nuclei;
(2) cells with bipolar, spindle-shaped, and long nuclei; (3)
cells with a tripolar cytoplasm and thick prolongations; (4)
cells with multipolar cytoplasm and fibroid and undulating
prolongations; (5) cells with multipolar cytoplasm that invade
the vasculature. Río Hortega reached the conclusion, albeit
indefinite, that there are two basic neoplastic types in the
FIGURE 4 | Example of fibrous astrocytoma (taken from Río-Hortega,
1933a).
FIGURE 5 | Examples of oligodendrocytoma (taken from Río-Hortega,
1933a).
formations he studied: one characterized by long elements
(Schwann oligodendrocytes) and another defined by multipolar
elements that give it the appearance of astrocytes (Ortiz de Picon,
1983).
CLASSIFICATION OF CENTRAL NERVOUS
SYSTEM TUMORS AFTER RÍO HORTEGA
Current classifications of nervous system tumors are mixed,
based on cytological and histogenetic criteria, as well as on
histopathological variants that are of clinical and prognostic
importance.
The main studies published after Río Hortega include that of
Kernohan and Sayre (1952), Miller et al. (1952) who began to
grade gliomas by establishing a correlation between microscopy
findings, degree of malignancy, and prognosis.
In 1965, Zülch stressed the importance of other factors, such as
patient survival, and included the concept of clinical malignancy
(Zülch, 1965). Finally, the first classification of the World Health
Organization was published in 1979 (Zülch, 1979) and classified
tumors as follows:
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FIGURE 6 | Neurocytoma. Note the gangliocytic cells and a plexus of
unmyelinated fibers (taken from Río-Hortega, 1933a).
FIGURE 7 | Neurinoma. Grouping of the nuclei in rows or palisades (taken
from Río-Hortega, 1933a).
(1) Tumors of neuroepithelial tissue, including astrocytoma,
glioblastoma multiforme, oligodendroglioma,
ependymoma, pinealcytoma, medulloblastoma,
gangliocytoma, ganglioglioma, and neuroblastoma.
(2) Meningeal tumors, such as meningioma and meningeal
sarcoma.
(3) Tumors of nerve sheath cells, such as neurinoma and
neurofibroma.
(4) Primary cerebral lymphoma.
(5) Tumors arising in blood vessels, such as hemangioblastoma.
(6) Germ cell tumors, such as germinoma and teratoma.
(7) Metastatic tumors.
(8) Malformative tumors and tumor-like lesions, such as
craniopharyngioma, epidermoid cyst, dermoid cyst, and
colloid cyst of the third ventricle.
(9) Local extensions from regional tumors, such as glomus
jugulare tumor and chordoma.
(10) Tumors of the anterior pituitary, such as pituitary adenoma.
(11) Unclassified tumors.
This classification serves as the basis for the subsequent
editions of the World Health Organization classification
until the year 2007 and the subgroups that are currently
FIGURE 8 | Meningeal exothelioma. The disordered cells are forming
clusters and concentric layers or acervuli (taken from Río-Hortega, 1933a).
being incorporated. The most notable new additions are as
follows:
(1) Variants of grade 1 astrocytomas, such as fibrillary,
protoplasmic, and gemistocytic astrocytoma.
(2) Pilocytic astrocytoma as an independent entity.
(3) Subependymal giant cell astrocytoma.
(4) Astroblastoma.
(5) Anaplastic (malignant) astrocytoma.
A distinction is also made between oligodendroglial tumors
and oligoastrocytic tumors [oligoastrocytomas and anaplastic
(malignant) oligodendrogliomas].
Within the ependymal tumors and colloid plexus tumors, it
is important to distinguish between variants of ependymomas,
such as myxopapillary ependymoma, papillary ependymoma,
subependymoma, and anaplastic ependymoma. At the level of
the colloid plexus, we must distinguish between colloid plexus
papilloma and colloid plexus carcinoma.
The neuronal tumors include variants such as gangliocytoma,
ganglioglioma, ganglioneuroblastoma, gangliocytoma, anaplastic
(malignant) ganglioglioma, and neuroblastoma.
Among the poorly differentiated and embryonal tumors it
is important to identify glioblastoma (with its two subvariants,
glioblastoma with a sarcomatous component and giant cell
glioblastoma), medulloblastoma, medulloepithelioma, primitive
polar spongioblastoma, and gliomatosis cerebri.
The classification covers tumors of the meningeal and related
tissues, such as meningioma, with at least 11 morphological
variants depending on the predominance of the Schwann,
angiomatous, and papillary component. Similarly, the anaplastic
(malignant) variant of meningioma is a distinct entity.
The classification still includes vascular tumors (e.g.,
hemangioblastoma and a malignant variant known as
monstrocellular carcinoma), primary malignant lymphoma,
and several variants of germ cell tumors. The previously cited
group of malformative tumors and tumor-like lesions is extended
to include enterogenic cysts, lipoma, hypothalamic neuronal
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hamartoma, nasal glial heterotopia (nasal glioma), as well
as various vascular malformations (capillary telangiectasia,
arteriovenous malformations, and Sturge-Weber disease).
The 2007 classification continues to include new entities,
mainly anatomical-clinical conditions where it is very important
to distinguish between gliomas with a high and low degrees of
malignancy based on cytological criteria. The new types of low-
grade glioma described include angiocentric gliomas, which are
variants of glioneuronal tumors (e.g., rosette-forming or papillary
tumors), and cytological variants of tumors of the anterior
pituitary (e.g., pituicytoma and spindle cell oncocytoma). We can
also distinguish between pilocytic tumors and their pilomyxoid
variants, which have a poorer clinical prognosis (Louis et al.,
2007).
In the coming years, it will be necessary to add the molecular
abnormalities underlying the transformation and malignancy of
these tumors. Our knowledge is expected to increase thanks
to amplification of genes such as EGFR in glioblastoma, loss
of alleles on chromosomes 1p and 19p in oligodendroglioma,
and mutations in genes such as in p53 and IDH1 in low-grade
astrocytoma that progresses to malignant astrocytoma. Intra-
and inter-tumoral heterogeneity could be understood as resulting
from cancer stem cells and the accumulation of variousmolecular
abnormalities.
As has occurred with other types of tumor, especially
lymphoma, whose classifications have for decades been based
merely on morphological or clinical criteria, a joint approach to
classification is probably the most suitable for clinical practice.
Cytological abnormalities, location, and histopathological
characteristics could facilitate a more in-depth study of the
various types of tumor. It is important to remember that the
major objective of any classification is that the information it
provides be of use in clinical practice. Only thus can the patient
receive the best and most personalized treatment possible.
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